유사한 콘텐츠 찾기

소스 채널 @phpdevelopersuz · Post #3292 · 8월 14일

🥳Bugun Telegram 10 yoshga to'ldi. Pavel Durovtug'ilgan kun haqida shunday dedi: Atigi oʻn yil ichida Telegram 800 milliondan ortiq faol foydalanuvchilarga ega boʻldi. Yillar davomida ko'plab yangilanishlar va takomillashtirishlar orqali Telegram zamonaviy xabar almashish tajribasi qanday bo'lishi kerakligini qayta belgilab berdi. Telegram uchun navbatdagi qadam - bu xabar almashishdan tashqariga chiqish va umuman, ijtimoiy tarmoqlarda innovatsiyalarni rivojlantirish. Biz mashhurligimizdan milliardlab odamlarning hayotini yaxshi tomonga o'zgartirish, sayyoramizdagi odamlarni ilhomlantirish va ko'tarish uchun foydalanishimiz kerak. Bugungi kunda barcha foydalanuvchilar uchun hikoyalarning bosqichma-bosqich chiqarilishi Telegram tarixidagi ushbu yangi bosqichning boshlanishini anglatadi. O'tgan o'n yillik hayajonli bo'lsa-da, keyingi 10 yil Telegram o'zining haqiqiy salohiyatiga erishadigan vaqt bo'ladi. 🥳 #durov#telegram#10yosh ✅@TGraphUz | 📺YouTube

Hashtags

#durov #telegram #10yosh

결과

2개의 유사한 게시물이 발견되었습니다

검색: #drugdevelopment

当前筛选 #drugdevelopment清除筛选

Crypto M - Crypto News

@CryptoM · Post #64470 · 2026. 04. 09. AM 01:45

유사 찾기 보기

🚀 Hong Kong's Innovative Drug Sector Gains Momentum Hong Kong's innovative drug sector is experiencing a surge, with several companies showing significant gains. According to Jin10, Ascletis Pharma (01672.HK) saw an increase of over 3%, while Hansoh Pharmaceutical (03692.HK) rose by more than 2%. Other companies such as WuXi AppTec (02359.HK) and Sihuan Pharmaceutical (00460.HK) also followed suit with upward trends. #HongKong#Pharmaceuticals#Biotech#Innovation#StockMarket#Healthcare#DrugDevelopment

Hashtags

#hongkong #pharmaceuticals #biotech #innovation #stockmarket #healthcare #drugdevelopment

Venture Village Wall 🦄

@venturevillagewall · Post #3642 · 2024. 12. 21. AM 10:23

유사 찾기 보기

PeproMene Bio Secures $11M Round PeproMene Bio, Inc., a clinical-stage biotech firm based in Irvine, CA, has successfully raised $11 million in funding. The investment round closed on December 18, 2024, focusing on innovative therapies targeting cancers and immune disorders. More info: PeproMene Bio #Biotech#Funding#Cancer#ImmuneDisorders#California#ClinicalStage#Therapies#Investment#Healthcare#Innovation#PeproMeneBio#Pharmaceuticals#MedicalResearch#DrugDevelopment

Hashtags

#biotech #funding #cancer #immunedisorders #california #clinicalstage #therapies #investment #healthcare #innovation #pepromenebio #pharmaceuticals #medicalresearch #drugdevelopment